9. Veeva Systems Inc. (NYSE:VEEV)
Veeva Systems Inc. (NYSE: VEEV) ranks No. 9 among the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds, and the company brings a different kind of AI healthcare story to this list. Trading at $171.36, with the stock up 8.40%, Veeva Systems Inc. (NYSE: VEEV) is backed by 62 hedge fund holders and remains one of the most important cloud software companies serving the global life sciences industry. While many AI healthcare stocks focus on diagnosis, medical devices, robotics, or drug discovery, Veeva Systems Inc. (NYSE: VEEV) plays in the business engine behind pharmaceutical companies: content review, compliance, commercial operations, customer relationship management, clinical data, and regulated communications. That may sound less glamorous than a medical breakthrough, but in life sciences, regulatory compliance and content approval can directly affect how quickly medical and promotional information reaches doctors, patients, and healthcare systems.
On June 23, Veeva Systems Inc. (NYSE: VEEV) announced that it had acquired Copli and launched Veeva Falcon MLR, an agentic medical, legal, and regulatory content-review platform made available immediately. The launch is important because the medical, legal, and regulatory review process, often called MLR, has long been one of the slowest and most manual parts of pharmaceutical content operations. Before a life sciences company can distribute promotional or medical content, that material usually needs to be checked against approved labels, medical claims, regulatory rules, local market requirements, and internal compliance standards. Veeva Systems Inc. (NYSE: VEEV) said Veeva Falcon MLR automates these reviews by checking materials against approved labels and local regulations, giving life sciences companies a potential way to reduce manual work and speed up approval cycles.
The company said Veeva Falcon MLR has the potential to eliminate more than 70% of manual MLR work over the next five years, which is exactly the kind of productivity number that can catch Wall Street’s attention. In healthcare and pharmaceuticals, artificial intelligence is often most powerful when it automates repetitive but highly regulated tasks. Copli CEO Jacob Scheel-Bech described the launch as “a fundamental shift” in content review, saying the acquisition would help scale the company’s vision for AI-focused MLR while merging its technology with Veeva PromoMats. That is significant because Veeva PromoMats is already widely used in life sciences commercial content operations, and adding AI review capabilities could make the platform more valuable for existing customers.
Emma Hyland, vice president of Veeva Commercial Content, said the MLR process has long slowed the delivery of information to patients and physicians. Her point cuts straight to the business and healthcare value of the launch. If AI can automate routine review work, then medical, legal, and regulatory reviewers can spend more time on higher-value decisions instead of repetitive checks. For pharmaceutical companies, shorter review cycles could mean faster content delivery, better responsiveness to market changes, and more efficient commercial operations. For investors looking for AI-powered healthcare stocks, healthcare software stocks, life sciences cloud stocks, and digital health technology stocks, Veeva Systems Inc. (NYSE: VEEV) offers exposure to a high-value software layer that supports the pharmaceutical industry from behind the scenes.
Veeva Systems Inc. (NYSE: VEEV) provides cloud-based software for the life sciences market across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company’s business is built around helping pharmaceutical, biotechnology, and medical technology companies manage complex, regulated workflows. That makes Veeva Systems Inc. (NYSE: VEEV) a strong example of how AI in healthcare is not limited to hospitals or laboratories. Sometimes, the real opportunity is in software systems that make healthcare companies faster, more compliant, and more efficient. With Veeva Falcon MLR, Veeva Systems Inc. (NYSE: VEEV) is pushing deeper into AI-powered workflow automation, and that could help the company remain one of the more interesting healthcare technology stocks for long-term investors.
Click next to see the following stock...
